🔬 Exciting Announcement! 🔬

We are thrilled to announce that Aureka Biotechnologies, Inc. will be participating in PEGS Boston 2024, one of the most anticipated events in the biotech industry! Join us from May 13-17 as we delve into the latest advancements and innovations shaping the future of biologics.

We are especially proud to have our VP of Biology, Dr. Alon Wellner, speaking at the Engineering track on the topic: "Rapid and Scalable Antibody Engineering by Autonomous Hypermutation in Yeast". He will be sharing insights into our groundbreaking approach, where antibody fragments are encoded on an error-prone DNA replication system and mutate through yeast culturing for antigen binding. This process swiftly produces high-affinity clones in under two weeks, enriching training data sets for our AI models.

Don't miss out on this opportunity to gain invaluable knowledge and connect with industry leaders. Be sure to mark your calendars and join us at PEGS Boston 2024!